NexGel Q2 FY26 gross profit falls 11.84% to $1.11 million; revenue rises 27.8% to $3.69 million
Reuters2026/08/17 10:36- NexGel posted Q2 revenue of $3.69 million, up 27.8% year over year, driven by $814,000 of new Biomaterial product sales.
- Gross profit fell to $1.11 million from a year earlier; gross margin dropped 13.5 percentage points to 30.1%.
- Selling, general and administrative expenses jumped to $3.59 million, up 89.8%, on BioNX Surgical buildout costs and Celularity license amortization.
- For the first half, revenue rose 11.4% to $6.34 million, while gross margin slid 8.8 percentage points to 34.2%.
- Cash and cash equivalents ended June 30 at $1.71 million; working capital swung to negative $8.27 million from $1.38 million at year-end.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ledger CEO: 'Total Safety Doesn't Exist'
Automotive Properties REIT declares August distribution of $0.0699 per unit
NexGen Energy (NXE.US) rises over 7%: Rook I launches a CAD 2.2 billion construction project; frequent communication with BHP sparks speculation about its entry
NexGen Energy is maintaining regular communication and sharing relevant information with global mining giant BHP regarding the Rook I uranium project located in Saskatchewan, Canada.
CB Financial Chief Credit Officer Stephen Cobain disposes of 1,500 shares worth $43,684.2
Crypto prices
More
